Published in Ann Thorac Surg on June 01, 2007
Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. Endocr Relat Cancer (2008) 1.02
Paraganglioma of the mediastinum: challenges in diagnosis and surgical management. J Cardiothorac Surg (2010) 0.97
Thoracoscopic resection of functional posterior mediastinal paraganglioma: a case report. J Thorac Dis (2014) 0.75
Mediastinal paraganglioma: complete resection using video-assisted thoracoscopic surgery. Korean J Thorac Cardiovasc Surg (2014) 0.75
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet (2009) 7.07
Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A (2008) 4.75
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys (2006) 4.22
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res (2002) 3.90
Aortic valve surgery after previous coronary artery bypass grafting with functioning internal mammary artery grafts. Ann Thorac Surg (2002) 2.88
Extensive endarterectomy and reconstruction of the left anterior descending artery: early and late outcomes. J Thorac Cardiovasc Surg (2012) 2.71
Tissue valve is the preferred option for patients aged 60 and older. Circulation (2013) 2.69
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg (2004) 2.53
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg (2005) 2.53
Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am J Respir Cell Mol Biol (2003) 2.45
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol (2003) 2.36
Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg (2012) 2.09
Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98
Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg (2008) 1.89
One thousand minimally invasive valve operations: early and late results. Ann Surg (2004) 1.88
Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. Anesthesiology (2009) 1.85
Management of High-Throughput DNA Sequencing Projects: Alpheus. J Comput Sci Syst Biol (2008) 1.85
Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg (2004) 1.82
Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. Ann Thorac Surg (2006) 1.79
Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations. Ann Thorac Surg (2007) 1.78
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res (2009) 1.73
Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 1.68
Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics (2010) 1.63
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res (2006) 1.61
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res (2008) 1.60
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol (2005) 1.60
Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst (2003) 1.59
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg (2003) 1.56
Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet (2009) 1.52
Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res (2004) 1.51
Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol (2008) 1.51
Antireflux operation for gastroesophageal reflux after Roux-en-y gastric bypass for obesity. Ann Thorac Surg (2005) 1.49
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol (2005) 1.44
Minimal access surgery of ascending and proximal arch of the aorta: a 9-year experience. Ann Thorac Surg (2007) 1.43
Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg (2010) 1.42
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest (2002) 1.40
Early and late outcomes of 1000 minimally invasive aortic valve operations. Eur J Cardiothorac Surg (2008) 1.39
Acute hemodynamic collapse after induction of general anesthesia for emergent pulmonary embolectomy. Anesth Analg (2006) 1.38
Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg (2011) 1.34
Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest (2004) 1.34
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg (2006) 1.32
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg (2013) 1.31
Reduction in incidence of deep sternal wound infections: random or real? J Thorac Cardiovasc Surg (2009) 1.25
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg (2009) 1.25
Early and late outcomes in minimally invasive mitral valve repair: an eleven-year experience in 707 patients. J Thorac Cardiovasc Surg (2009) 1.24
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res (2006) 1.23
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol (2006) 1.23
Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer (2009) 1.23
A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev (2003) 1.22
Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J (2009) 1.20
Molecular pathways and therapeutic targets in lung cancer. Oncotarget (2014) 1.16
Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest (2005) 1.14
Conversion to full sternotomy during minimal-access cardiac surgery: reasons and results during a 9.5-year experience. J Thorac Cardiovasc Surg (2007) 1.14
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis (2002) 1.14
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis (2008) 1.14
Left anterior descending coronary endarterectomy: early and late results in 196 consecutive patients. Ann Thorac Surg (2004) 1.13
A novel classification of lung cancer into molecular subtypes. PLoS One (2012) 1.13
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res (2009) 1.12
Lung resection in patients with preoperative FEV1 < 35% predicted. Chest (2005) 1.11
Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Clin Cancer Res (2005) 1.09
Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis (2002) 1.09
Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. J Natl Cancer Inst (2009) 1.06
Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol (2003) 1.06
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorac Cardiovasc Surg (2008) 1.06
Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer (2011) 1.06
The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. Chest (2004) 1.05
Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer (2011) 1.05
Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res (2011) 1.04
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg (2011) 1.03
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol (2012) 1.01
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. Am J Respir Cell Mol Biol (2008) 1.01
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol (2007) 1.01
Minimally invasive mitral valve repair suggests earlier operations for mitral valve disease. J Thorac Cardiovasc Surg (2003) 1.00
Peripheral blood gene expression profiles in COPD subjects. J Clin Bioinforma (2011) 0.99
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. Neoplasia (2011) 0.98
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg (2013) 0.98
Long-term survival and quality of life justify cardiac surgery in the very elderly patient. Ann Thorac Surg (2011) 0.96
Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome. Anesthesiology (2015) 0.95
Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One (2012) 0.95
Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect (2008) 0.94
Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer (2011) 0.94
Images in clinical medicine. Giant syphilitic aortic aneurysm. N Engl J Med (2011) 0.94
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg (2009) 0.94
Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg (2011) 0.93
Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma. Clin Cancer Res (2010) 0.92
Primary Ewing sarcoma invading the heart: resection and reconstruction. J Thorac Cardiovasc Surg (2007) 0.92
Evaluation of perfusion and viability in hypothermic non-beating isolated porcine hearts using cardiac MRI. Int J Cardiovasc Imaging (2005) 0.91
Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. Ann Thorac Surg (2004) 0.91
Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events. J Cell Mol Med (2005) 0.90
Multimodal imaging for improved diagnosis and treatment of cancers. Cancer (2014) 0.90
Bronchopleural fistula repair during Clagett closure utilizing a collagen matrix plug. Ann Thorac Surg (2007) 0.90
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer (2010) 0.90
Rat intubation and ventilation for surgical research. J Invest Surg (2006) 0.89
Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation. Clin Cancer Res (2012) 0.89
Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. Cancer Res (2010) 0.89
Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology (2010) 0.89